References
-
1) Cinacalcet Targets the Neurokinin-1 Receptor and Inhibits PKCδ/ERK/P65 Signaling to Alleviate Dextran Sulfate Sodium-Induced Colitis.
Product: NK1R Antibody (#DF4996)Year: 2021Journal: Front PharmacolImpactFactor: 5.6DOI: 10.3389/fphar.2021.735194PMID: 34880751 -
2) Melatonin reduces intramuscular fat deposition by promoting lipolysis and increasing mitochondrial function.
Product: MTR1B Antibody (#DF4994)Year: 2019Journal: J LIPID RESImpactFactor: 5DOI: 10.1194/jlr.M087619PMID: 30552289 -
3) Motilin and its receptor are expressed in the dorsal horn in a rat model of acute incisional pain: Intrathecal motilin injection alleviates pain behaviors.
Product: MTLR Antibody (#DF4993)Year: 2023Journal: Front NeurosciImpactFactor: 4.3DOI: 10.3389/fnins.2023.1104862PMID: 36816129 -
4) Biomimetic in vitro respiratory system using smooth muscle cells on ECIS chips for anti-asthma TCMs screening.
Product: TAS2R10 Antibody (#DF5157)Year: 2021Journal: ANAL CHIM ACTAImpactFactor: 5.7DOI: 10.1016/j.aca.2021.338452PMID: 33926702 -
5) Dihydrotanshinone I Inhibits Pancreatic Cancer Progression via Hedgehog/ Gli Signal Pathway.
Product: SMO Antibody (#DF5152)Year: 2023Journal: Curr Cancer Drug TargetsImpactFactor: 2.3DOI: 10.2174/1568009623666230328123915PMID: 37018533 -
6) Ubenimex suppresses glycolysis mediated by CD13/Hedgehog signaling to enhance the effect of cisplatin in liver cancer.
Product: SMO Antibody (#DF5152)Year: 2023Journal: Transl Cancer ResImpactFactor: 1.5DOI: 10.21037/tcr-23-435PMID: 37969369 -
7) Effects of metformin on Sonic hedgehog subgroup medulloblastoma progression: In vitro and in vivo studies.
Product: SMO Antibody (#DF5152)Year: 2022Journal: FRONT PHARMACOLImpactFactor: 5.6DOI: 10.3389/fphar.2022.928853PMID: 36278239 -
8) Disruption of Gprasp2 down-regulates Hedgehog signaling and leads to apoptosis in auditory cells.
Product: SMO Antibody (#DF5152)Year: 2021Journal: BIOCHEM BIOPH RES COImpactFactor: 2.5DOI: 10.1016/j.bbrc.2021.08.034PMID: 34418635 -
9) Sonic hedgehog pathway mediates genistein inhibition of renal cancer stem cells.
Product: SMO Antibody (#DF5152)Year: 2019Journal: ONCOL LETTImpactFactor: 2.5DOI: 10.3892/ol.2019.10657PMID: 31452785 -
10) GLI1 activation by non-classical pathway integrin αvβ3/ERK1/2 maintains stem cell-like phenotype of multicellular aggregates in gastric cancer peritoneal metastasis.
Product: SMO Antibody (#DF5152)Year: 2019Journal: CELL DEATH DISImpactFactor: 8.1DOI: 10.1038/s41419-019-1776-xPMID: 31366904 -
11) Curcumin mitigates the epithelial-to-mesenchymal transition in biliary epithelial cells through upregulating CD109 expression.
Product: SMO Antibody (#DF5152)Year: 2019Journal: DRUG DEVELOP RESImpactFactor: 3.5DOI: 10.1002/ddr.21580PMID: 31403228 -
12) Annexin A2 (ANXA2) regulates the transcription and alternative splicing of inflammatory genes in renal tubular epithelial cells.
Product: SCTR Antibody (#DF5151)Year: 2022Journal: BMC GENOMICSImpactFactor: 3.5DOI: 10.1186/s12864-022-08748-6 -
13) PAQR5 inhibits the growth and metastasis of clear cell renal cell carcinoma by suppressing the JAK/STAT3 signaling pathway.
Product: MPRG Antibody (#DF4988)Year: 2023Journal: Cell Oncol (Dordr)ImpactFactor: 4.9DOI: 10.1007/s13402-023-00813-wPMID: 37126128 -
14) Second-generation antipsychotics induce cardiotoxicity by disrupting spliceosome signaling: Implications from proteomic and transcriptomic analyses.
Product: HRH1 Antibody (#DF4980)Year: 2021Journal: Pharmacol ResImpactFactor: 9.1DOI: 10.1016/j.phrs.2021.105714PMID: 34098070 -
15) Prognostic value of CXCL17 and CXCR8 expression in patients with colon cancer.
Product: GPR35 Antibody (#DF4973)Year: 2020Journal: ONCOL LETTImpactFactor: 2.5DOI: 10.3892/ol.2020.11819PMID: 32782587